SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: arnie h who wrote (1811)4/9/2005 11:27:14 PM
From: richardred  Read Replies (1) | Respond to of 2173
 
Last time I was surprised to see the stock held up fairly stable on the Symlin extension wait. I just hope, as it should be, it will be based on the past trials data, without undue influence. Of recent, It seems more speculation on FDA approvals are based on it going gun-shy. This because, of recent recalls, and the tone it needs to scrutinize more throughly.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News